Given the central role of NUSAP1 in pro-cancer signaling pathways, targeting NUSAP1 for inhibition may enable coordinated blockage of multiple pathways, thereby establishing it as a highly promising therapeutic target for cancer treatment. Here, NUSAP1 is linked to cancer.